Ceng Kai - Net Worth and Insider Trading
Ceng Kai Net Worth
The estimated net worth of Ceng Kai is at least $11 Million dollars as of 2024-06-23. Ceng Kai is the Directors, executives of Jafron Biomedical Co Ltd and owns about 402,000 shares of Jafron Biomedical Co Ltd (SZSE:300529) stock worth over $11 Million. Details can be seen in Ceng Kai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ceng Kai has not made any transactions after 2021-06-28 and currently still holds the listed stock(s).
Transaction Summary of Ceng Kai
Ceng Kai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ceng Kai owns 1 companies in total, including Jafron Biomedical Co Ltd (SZSE:300529) .
Click here to see the complete history of Ceng Kai’s form 4 insider trades.
Insider Ownership Summary of Ceng Kai
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:300529 | Jafron Biomedical Co Ltd | 2021-06-28 | Directors & executives |
Ceng Kai Latest Holdings Summary
Ceng Kai currently owns a total of 1 stock. Ceng Kai owns 402,000 shares of Jafron Biomedical Co Ltd (SZSE:300529) as of June 28, 2021, with a value of $11 Million.
Latest Holdings of Ceng Kai
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:300529 | Jafron Biomedical Co Ltd | 2021-06-28 | 402,000 | 27.45 | 11,034,900 |
Holding Weightings of Ceng Kai
Ceng Kai Form 4 Trading Tracker
According to the SEC Form 4 filings, Ceng Kai has made a total of 5 transactions in Jafron Biomedical Co Ltd (SZSE:300529) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Jafron Biomedical Co Ltd is the sale of 70,000 shares on June 28, 2021, which brought Ceng Kai around $6 Million.
Insider Trading History of Ceng Kai
- 1
Ceng Kai Trading Performance
GuruFocus tracks the stock performance after each of Ceng Kai's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ceng Kai is 10.07%. GuruFocus also compares Ceng Kai's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ceng Kai within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ceng Kai's insider trading performs compared to the benchmark.
Performance of Ceng Kai
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.98 | | | | | |
| Relative Return to S&P 500(%) | -5.75 | | | | | |
Ceng Kai Ownership Network
Ceng Kai Owned Company Details
What does Jafron Biomedical Co Ltd do?
Who are the key executives at Jafron Biomedical Co Ltd?
Ceng Kai is the Directors & executives of Jafron Biomedical Co Ltd. Other key executives at Jafron Biomedical Co Ltd include Executives He Xiao Lian , Directors & Directors & and Executives Dong Fan , and Directors & executives Tang Xian Min .
Jafron Biomedical Co Ltd (SZSE:300529) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jafron Biomedical Co Ltd (SZSE:300529) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jafron Biomedical Co Ltd (SZSE:300529) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jafron Biomedical Co Ltd (SZSE:300529)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jafron Biomedical Co Ltd Insider Transactions
Ceng Kai Mailing Address
Above is the net worth, insider trading, and ownership report for Ceng Kai. Currently GuruFocus does not have mailing address information for Ceng Kai.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
